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Summary GABA(B) receptor1 (GABABR1) gene is one of the susceptibility genes for
temporal lobe epilepsy (TLE). Recently, it is reported that the GABABR1 polymorphism
(G1465A) conferred a highly increased susceptibility to TLE. We performed a case-
control study to confirm the findings. The study included a total of 112 nonlesional TLE
patients and 124 controls of Chinese ancestry. Our study did not show any polymorph-
ism in this locus, and suggested this polymorphism may not be a strong susceptibility
factor for TLE among Chinese population.
# 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Temporal lobe epilepsy (TLE) is one of the most
common epilepsy syndromes. It is often associated
with hippocampal sclerosis (HS). Although the etiol-
ogy of TLE remained highly controversial, growing
evidence indicated that genetic predisposition
appears to be an important causal factor of TLE in
the last few years. GABA (g-aminobutyric acid) is
the principal inhibitory neurotransmitter in the
human brain, which exerts its effects mainly
through two receptor subtypes termed A and B.1
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doi:10.1016/j.seizure.2005.09.009system, specifically in CA1 and CA3 pyramidal cells
of hippocampal formation, and in dentate gyrus
granule cells.2 So malfunctioning of the GABA-ergic
system has been proposed as one cause for epilepsy.
Recently, Gambardella et al.3 found a strong asso-
ciation between GABABR1 gene polymorphism
(G1465A) and TLE in a European group. The biological
significanceof suchafindingneeds tobeconfirmedby
independent population samples. So we performed a
case-control test to research if thepolymorphismwas
susceptibility for TLE of Chinese ancestry.Materials and methods
Data and evaluation procedures on our patients with
TLE have been reported in our previous study.4 Theby Elsevier Ltd. All rights reserved.
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Table 1 Clinical and epidemiologic characteristics in patients with TLE and in controls.4
TLE (total = 112) Controls (total = 124)
HS+ (n = 67) HS (n = 45)
Gender (F/M) 32/35 16/29 56/68
Age (years) 31.28  9.84 32.13  10.65 29.66  7.41
Age at seizure onset (years) 16.46  8.99 25.76  14.25
History of PFC, n (%) 28 (42) 7 (16)study consisted of 112 outpatients with nonlesional
TLE who visited the Hakuai Epilepsy Center in Peking
Union Medical College Hospital from December 2000
to July 2001. Informed consent was obtained from
all subjects. Diagnosis of nonlesional TLE was based
on comprehensive clinical, neuropsychological,
EEG, and MR evaluations. According to the findings
of MRI, patients were divided into two groups: 67
TLE patients with hippocampal sclerosis (HS) (TLE-
HS+) and 45 patients without HS (TLE-HS). The
main clinical and epidemiologic data are summar-
ized in Table 1. One hundred and twenty-four unre-
lated neurologically normal subjects, matched for
age, sex, ethnicity, were also randomly selected as
controls. Both the patients and the controls were of
Chinese ancestry and came from the northern
regions of China.
Venous blood was drawn from each individual,
and genomic DNAwas prepared from whole blood by
using a standard proteinase K digestion and phenol-
chloroform method. A 441-bp fragment in position
of GABABR1 exon 7 was amplified by polymerase
chain reaction (PCR). Primer pairs and the condi-
tions for the PCR were previously described.3,5 The
PCR products were digested with restriction enzyme
EagI (the G to A transition destroys an EagI restric-
tion site, the 441-bp amplification fragment cannot
be digested into 258- and 183-bp fragments in indi-
viduals carrying such a DNA change), run on a 12%
polyacrylamide gel, and viewed and photographed
under ultraviolet light after staining with ethidium
bromide.Results
In contrast with the previous study in Europe, our
study did not show any polymorphism in this locus,
only genotype G/G was observed in all patients and
controls.Discussion
In 1998, the gene encoding GABABR1 was cloned,
several polymorphisms of human GABABR1 genehave been identified, but only two were missense
mutations.5 The missense mutation (G1465A) led to
an amino acid substitution Gly489Ser within the N-
terminal extracellular domain of the GABA(B)
receptor, which was necessary for heteromeric
assembly of such a receptor and, therefore, might
affect its ligand binding properties. Gambardella
et al. showed the GABABR1 gene polymorphism
(G1465A) conferred a highly increased susceptibility
to TLE. The A/G genotype was found in 17% of the
141 patients with TLE and in only 0.5% of the 372
controls (p < 0.0001).3 The authors also found that
patients carrying the A allele had a significantly
higher risk (p = 0.003, OR = 6.47, 95% CI = 2.02—
20.76) of developing drug-resistant TLE. Further-
more, the age at onset of seizures tended to be
lower in patients with A/G genotype, but the dif-
ference was not significant.
In the last few years, significant association with
sporadic TLE have been reported in IL-1b,6 APOE,7
PDYN,8 and PRNP.9 Otherwise, results from follow-
up studies were conflicted. This study also failed to
document any association between GABABR1
(G1465A) variation and TLE, only genotype G/G
was observed in all patients and controls.
Failure to replicate a genetic association study
could be caused by several factors, and they have
been discussed extensively in previous studies.10
Patients in the present study and the previous study
all met the inclusion criteria for nonlesional TLE.
The sample sizes were also similar (112 in our study
and 141 in the original report). We must keep in
mind that common diseases arise from interaction of
several genes, with additional environmental influ-
ences, and are much more complex, which can lead
to the discrepancy between independent popula-
tions in gene-disease associations. In addition, rare
susceptibility alleles may be ethno-geographically
localized, and dissimilar disease-causing alleles may
predominate in different populations, which may
also result in nonreplication.
Though further studies in independent population
samples are needed to determine whether the
GABABR1 (G1465A) variation is a susceptibility fac-
tor for TLE, our results suggest that this mutation
may not be a strong susceptibility factor for TLE.
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